Propionic Acid

Propionic Acid

SCHEMBL585470

CCC(=O)O.c1cc2cc-2c1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.50
KMO O15229 1/20 0.50
BCL2 P10415 1/20 0.48
MAPT P10636 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
PTGER1 P34995 1/20 0.47
PTGER4 P35408 1/20 0.47
PTGER3 P43115 1/20 0.47
PTGER2 P43116 1/20 0.47
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
ACMSD Q8TDX5 1/20 0.44
PTGS2 P35354 1/20 0.43
PTPN1 P18031 1/20 0.42
MEN1 O00255 1/20 0.42
ESR1 P03372 1/20 0.42
KMT2A Q03164 1/20 0.42
LMNA P02545 2/20 0.42
MGLL Q99685 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butanone SCHEMBL27536691 0.85 ALDH1A1 (0.50) KMOBCL2MAPTSMN1; SMN2L3MBTL1
SCHEMBL28261370 0.85 MMP12 (0.44) KMOBCL2MAPTSMN1; SMN2L3MBTL1
Biphenyl SCHEMBL1050110 0.84 SMN1; SMN2 (0.64) FFAR3MAPTSMN1; SMN2L3MBTL1PTGS2
Biphenyl SCHEMBL15333645 0.84 SMN1; SMN2 (0.64) FFAR3MAPTSMN1; SMN2L3MBTL1PTGS2
Butyric Acid SCHEMBL3208838 0.84 FFAR3 (0.56) FFAR3KMOBCL2SMN1; SMN2L3MBTL1
Biphenyl SCHEMBL27593503 0.82 SMN1; SMN2 (0.61) FFAR3MAPTSMN1; SMN2L3MBTL1PTGS2
Biphenyl SCHEMBL27339135 0.82 SMN1; SMN2 (0.61) FFAR3MAPTSMN1; SMN2L3MBTL1PTGS2
Biphenyl SCHEMBL27642147 0.82 SMN1; SMN2 (0.61) FFAR3MAPTSMN1; SMN2L3MBTL1PTGS2
Glycolic Acid SCHEMBL8854226 0.82 KMO (0.52) KMOBCL2PTGER1PTGER4PTGER3
Biphenyl SCHEMBL27481591 0.82 SMN1; SMN2 (0.61) FFAR3MAPTSMN1; SMN2L3MBTL1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8802119-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2014-08-12 US disclosed
US-20130338107-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2013-12-19 US disclosed
US-8541581-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2013-09-24 US disclosed
US-20120088738-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS ,INC (US) 2012-04-12 US disclosed
EP-2417115-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE Infinity Pharmaceuticals, Inc. (US) 2012-02-15 EP disclosed
WO-2010118159-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088738-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, CES1 FFAR3 4/4885KMO 553/4885BCL2 3686/4885
US-20130338107-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, FFAR3 FFAR3 3/4885KMO 569/4885BCL2 3427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.